In contrast, in different datasets lower expression of ILK is observed in bladder, brain, breast, cervical, colorectal, esophageal, head and neck, leukemia, lung, lymphoma, ovarian and prostate cancers (Figure 1B). Here, ILK is linked to prostate carcinoma.